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T
he recent systematic review by
Zhang et al. (1) prompted us to ex-
amine A1C and risk factor data that
were collected in Canada last year as part
of a series of CANRISK diabetes screening
projects (2). These data include both self-
reported risk factors required to calculate
the FINDRISC diabetes risk score (2) as
well as A1C and standard glucose tests
(fasting plasma glucose and 2-h 75-g oral
glucosetolerancetest[OGTT]).Theresult-
ing convenience sample of 1,057 adults
(aged 29–75 years) was obtained from a
mixed ethnic group from Vancouver,
West Toronto, and rural New Brunswick
(mean age 56 years, 57% white, and 70%
female). Using World Health Organiza-
tion (WHO) standard deﬁnitions, this
combinedsampleyieldedsigniﬁcantrates
of screen-detected diabetes (4%), isolated
impaired fasting glucose (IFG) (4%), iso-
lated impaired glucose tolerance (IGT)
(15%), and “high-risk prediabetes” (i.e.,
both IGT and IFG [3%]).
FINDRISC was developed from the
Finnish Diabetes Prevention Study and
provides a prediction of 10-year diabetes
risk based on eight risk factors (3). This al-
lows us to stratify the dataset according to
A1C strata used by Zhang et al. (1) in their
recentsystematicreviewandthencompare
the predicted (5-year) diabetes incidence
for FINDRISC versus their estimates
(except for A1C , 5.0% where we had
only three cases). The resulting 5-year di-
abetes incidence rates using FINDRISC
are consistently lower (the results of
Zhang et al. (1) are in parentheses): 1)
4% for A1C 5.0–5.49% (,9%), 2)6 %
for A1C 5.5–5.9% (9–25%), 3)9 %f o r
A1C 6.0–6.5% (25–50%), and 4)1 2 %
for A1C $ 6.1% (54%). As context, obe-
sity rates for these respective A1C groups
were 1) 9%, 2) 16%, 3) 26%, and 4) 36%
and for diabetes maternal history 1) 21%,
2) 21%, 3) 28%, and 4) 28%.
In conclusion, A1C review of Zhang
et al. (1) appears to overpredict future di-
abetes incidence, particularly for those
with high A1C levels; our FINDRISC re-
sults found no observed “steep increase
across the range of A1C from 5.0 to
6.5%,” but rather a steady increase in di-
abetes risk (2 to 3 percentage points of
incidence for each step upwards in A1C
category). Even the highest A1C category
(A1C .6.1%) is unlikely to exceed 12%
diabetes incidence over 5 years—this is
well below the 40% cumulative incidence
expected for “high-risk prediabetes” cases
(4,5). This “high-risk prediabetes” target
group has the largest ability to beneﬁt
from organized diabetes screening and
prevention, and yet it can only be deter-
mined by OGTT, which is rarely used in
opportunistic screening. Operational-
izingOGTTinorganizedscreeningwould
therefore depend on a triaged strategy in-
volving initial risk scoring tools such as
FINDRISC.
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